According to our (Global Info Research) latest study, the global Xanthan Gum for Pharmaceutical market size was valued at US$ 59.67 million in 2025 and is forecast to a readjusted size of US$ 86.38 million by 2032 with a CAGR of 5.7% during review period.
Xanthan Gum for Pharmaceutical refers to xanthan gum selected and quality-controlled for pharmaceutical, oral care, clinical nutrition and healthcare formulations. It is a high-molecular-weight anionic polysaccharide produced by the pure-culture fermentation of carbohydrate substrates using Xanthomonas strains, followed by purification, alcohol recovery, drying and milling. In strict pharmaceutical excipient applications, it normally requires pharmacopoeial compliance, excipient GMP control, microbial-limit control, residual-solvent control, heavy-metal control, batch consistency, traceability and regulatory documentation support. Its main formulation value lies in thickening, suspension stabilization, emulsion stabilization, gel formation, mucoadhesion, mouthfeel improvement and controlled or sustained drug release.
In 2025, global sales of Xanthan Gum for Pharmaceutical reached approximately 13 K tons, with an average global market price of around US$ 4,607/ton. Production capacity varies significantly among manufacturers, with gross profit margins ranging from approximately 20% to 50%.
Xanthan Gum for Pharmaceutical is positioned at the intersection of natural-origin rheology modifiers and pharmaceutical excipients. Demand mainly comes from oral liquid formulations, topical semi-solid products, controlled-release solid dosage forms, dental products, dysphagia products and clinical nutrition preparations. Compared with ordinary food-grade xanthan gum, pharmaceutical and healthcare customers place greater emphasis on quality systems and application validation, including pharmacopoeial compliance, GMP control, microbial limits, residual solvents, heavy metals, viscosity stability, batch consistency, supply continuity and regulatory documentation. Therefore, market entry barriers are not only based on fermentation capacity and cost, but also on quality control, registration support, customer audits and long-term formulation validation.
The market outlook remains structurally stable. Population ageing, growing demand for pediatric and geriatric-friendly dosage forms, expansion of dysphagia-related products, the convenience of oral liquid formulations, and rising use of topical and oral local delivery products all support the use of xanthan gum in pharmaceutical-related formulations. At the same time, natural-origin, non-animal, bio-based and biodegradable excipients are receiving more attention. Xanthan gum continues to provide formulation value in suspension stabilization, mouthfeel improvement, mucoadhesion, gel structuring and sustained-release matrices. Suppliers with multi-compendial compliance, low residual solvents, low bioburden and reliable supply are more likely to enter high-end customer systems.
However, the market also faces substitution competition and long qualification cycles. HPMC, CMC, hydroxyethyl cellulose, alginates, carbomers, povidone, pectin, guar gum, gellan gum and gelatin can perform similar functions in different dosage forms. Once a pharmaceutical formulation has been validated, manufacturers usually avoid changing excipient suppliers unless necessary. In addition, pharmacopoeial updates, regulatory audits, raw material traceability, microbial control and impurity management continue to raise compliance costs. Future competition will focus on regulatory documentation, global compliance capability, quality consistency, co-development with customers and application support for specific dosage forms.
This report is a detailed and comprehensive analysis for global Xanthan Gum for Pharmaceutical market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Xanthan Gum for Pharmaceutical market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Xanthan Gum for Pharmaceutical market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Xanthan Gum for Pharmaceutical market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Xanthan Gum for Pharmaceutical market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Xanthan Gum for Pharmaceutical
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Xanthan Gum for Pharmaceutical market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Fufeng Group, CP Kelco, Deosen Biochemical, Jianlong Biotechnology, Jungbunzlauer, IFF, Hebei Xinhe Biochemical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Xanthan Gum for Pharmaceutical market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Conventional
Clarified
Market segment by Appearance
Powder
Liquid
Market segment by Viscosity
< 1,600 mPa·s
≥ 1,600 mPa·s
Market segment by Application
Oral Drug
Ophthalmic Drug
Rectal Drug
Others
Major players covered
Fufeng Group
CP Kelco
Deosen Biochemical
Jianlong Biotechnology
Jungbunzlauer
IFF
Hebei Xinhe Biochemical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Xanthan Gum for Pharmaceutical product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Xanthan Gum for Pharmaceutical, with price, sales quantity, revenue, and global market share of Xanthan Gum for Pharmaceutical from 2021 to 2026.
Chapter 3, the Xanthan Gum for Pharmaceutical competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Xanthan Gum for Pharmaceutical breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Xanthan Gum for Pharmaceutical market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Xanthan Gum for Pharmaceutical.
Chapter 14 and 15, to describe Xanthan Gum for Pharmaceutical sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Xanthan Gum for Pharmaceutical. Industry analysis & Market Report on Xanthan Gum for Pharmaceutical is a syndicated market report, published as Global Xanthan Gum for Pharmaceutical Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Xanthan Gum for Pharmaceutical market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.